Alignment Healthcare Announces Secondary Offering

Rhea-AI Summary

Alignment Healthcare (NASDAQ: ALHC) announced an underwritten public offering on March 2, 2026, of 13,167,733 shares of common stock by an affiliate of General Atlantic, L.P.

The company will not receive any proceeds; J.P. Morgan is acting as underwriter and the offering is made under a Form S-3 shelf registration that became effective March 2, 2026.

Positive

• 13,167,733 shares offered by selling stockholder
• Offer increases public float and potential liquidity

Negative

• Company will receive no proceeds from this offering
• Potential share dilution from secondary sale into market

Key Figures

Secondary shares offered: 13,167,733 shares General Atlantic stake: 13,167,733 shares (6.6%) Price move: -5.88% +5 more

8 metrics

Secondary shares offered 13,167,733 shares Underwritten public offering by General Atlantic affiliate

General Atlantic stake 13,167,733 shares (6.6%) As of December 31, 2025 per Schedule 13G/A

Price move -5.88% Change prior to and around secondary offering announcement

Current price $19.67 Last close before/at news time

52-week range $11.625 – $23.87 Price vs. 52-week low and high levels

Short interest 22.44% Reported short interest as share of float

Shelf effective date 2026-03-02 Form S-3ASR automatic shelf registration effectiveness

Days to cover 4.78 days Based on reported short interest and volume

Market Reality Check

Price: $19.23 Vol: Volume 2,341,740 is sligh...

normal vol

$19.23 Last Close

Volume Volume 2,341,740 is slightly below 20-day average of 2,438,027 (relative volume 0.96). normal

Technical Trading above 200-day MA with price at $19.67 versus 200-day MA at $17.10.

Peers on Argus

ALHC fell 5.88% while key peers were mostly positive: OSCR +6.15%, PGNY +1.91%, ...

ALHC fell 5.88% while key peers were mostly positive: OSCR +6.15%, PGNY +1.91%, MOH +0.52%, CVS +2.14% and CLOV -0.49%, indicating stock-specific pressure from the secondary offering.

Historical Context

5 past events · Latest: Feb 23 (Neutral)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 23	Conference presentation	Neutral	-3.4%	Announcement of upcoming presentation at Leerink Partners Global Healthcare Conference.
Feb 05	Earnings call timing	Neutral	-0.8%	Scheduled date and webcast details for Q4 and full-year 2025 results.
Jan 21	Corporate recognition	Positive	+2.5%	First-time inclusion on 2026 Fortune World’s Most Admired Companies list.
Jan 20	Leadership & AI focus	Positive	+1.1%	Appointment of chief digital officer to advance AI and AVA platform.
Jan 12	Membership & guidance	Positive	+2.4%	Disclosure of 31% membership growth, 2026 membership outlook and EBITDA framework.

Pattern Detected

Recent fundamental and recognition news generally saw positive or modest reactions, while neutral conference announcements drew small declines. Today’s negative move on a selling-stockholder offering contrasts with earlier support for operating momentum headlines.

Recent Company History

Over the last few months, Alignment Healthcare reported strong operating momentum, including 31% year-over-year membership growth to 275,300 as of Jan. 1, 2026 and recognition on the 2026 Fortune World’s Most Admired Companies list. Leadership additions to accelerate AI-driven growth and multiple conference appearances underscored its Medicare Advantage focus. Most positive business updates saw modest share gains, while neutral scheduling news had limited impact. Against this backdrop, the current selling-stockholder secondary offering introduces technical supply without issuer proceeds, differing from prior fundamentally driven catalysts.

Regulatory & Risk Context

Active S-3 Shelf

Shelf Active

Active S-3 Shelf Registration 2026-03-02

An effective Form S-3ASR shelf registration dated 2026-03-02 allows Alignment Healthcare and named selling stockholders to offer various securities, including common stock, from time to time via prospectus supplements. As of this offering, recorded shelf usage count is 0.

Market Pulse Summary

This announcement detailed an underwritten public offering of 13,167,733 shares by a General Atlanti...

Analysis

This announcement detailed an underwritten public offering of 13,167,733 shares by a General Atlantic affiliate, structured as a secondary sale with no proceeds to Alignment Healthcare. It was conducted off an effective Form S-3ASR shelf dated 2026-03-02, highlighting flexibility for both the company and selling stockholders to transact via prospectus supplements. In context of recent strong growth and improved financials, investors may watch future shelf takedowns, sponsor ownership changes and overall trading liquidity as key factors.

Key Terms

underwritten public offering, shelf registration statement, form s-3, prospectus supplement, +1 more

5 terms

underwritten public offering financial

"announced the commencement of an underwritten public offering of 13,167,733 shares"

An underwritten public offering is when a company sells new shares of its stock to the public with the help of a financial firm, called an underwriter. The underwriter agrees to buy all the shares upfront, reducing the company's risk, and then sells them to investors. This process helps companies raise money quickly and confidently from a wide range of buyers.

shelf registration statement regulatory

"The offering is being made pursuant to a shelf registration statement on Form S-3"

A shelf registration statement is a document a company files with regulators that allows it to sell shares or bonds quickly when it’s a good time to raise money. It’s like having a pre-approved plan ready so the company can act fast without going through lengthy paperwork each time they want to sell, making fundraising more flexible.

form s-3 regulatory

"shelf registration statement on Form S-3, which has been filed by the Company"

Form S-3 is a legal document companies use to register their stock sales with the government, making it easier and faster for them to raise money by selling shares to investors. It’s like having a pre-approved shopping list that lets a company quickly sell new shares when they need funds, without going through a lengthy approval process each time.

prospectus supplement regulatory

"The offering will be made only by means of a prospectus supplement and an accompanying prospectus."

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

securities and exchange commission regulatory

"filed by the Company with the Securities and Exchange Commission (the "SEC")"

A national government agency that enforces rules for buying, selling and disclosing information about stocks and other investments, acting like a referee and scorekeeper for financial markets. It requires companies to share clear, regular financial and business information and investigates fraud or rule-breaking, which matters to investors because those rules and disclosures help ensure fair prices, reduce hidden risks and make it easier to compare investment choices.

AI-generated analysis. Not financial advice.

ORANGE, Calif., March 02, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) (“Alignment Healthcare” or the “Company”), an award-winning Medicare Advantage (MA) company, today announced the commencement of an underwritten public offering of 13,167,733 shares of its common stock by an affiliate of General Atlantic, L.P. (the “Selling Stockholder”). The Company will not receive any of the proceeds from the sale of the shares of its common stock being offered by the Selling Stockholder.

J.P. Morgan is acting as the underwriter for the proposed offering.

The offering is being made pursuant to a shelf registration statement on Form S-3, which has been filed by the Company with the Securities and Exchange Commission (the "SEC") and became effective upon filing on March 2, 2026. The offering will be made only by means of a prospectus supplement and an accompanying prospectus. You may obtain these documents for free by visiting EDGAR on the SEC website at www.sec.gov, or by contacting: J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by email at prospectus-eq_fi@jpmchase.com and postsalemanualrequests@broadridge.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Alignment Healthcare

Alignment Health is championing a new path in senior care that empowers members to age well and live their most vibrant lives. A consumer brand name of Alignment Healthcare (NASDAQ: ALHC), Alignment Health’s mission-focused team makes high-quality, low-cost care a reality for its Medicare Advantage members every day. Based in California, the company partners with nationally recognized and trusted local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology, AVA®. As it expands its offerings and grows its national footprint, Alignment upholds its core values of leading with a serving heart and putting the senior first.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements include, among others, statements concerning the expected closing of the offering. Forward-looking statements are subject to risks and uncertainties and are based on assumptions that may prove to be inaccurate, which could cause actual results to differ materially from those expected or implied by the forward-looking statements. Actual results may differ materially from the results predicted, and reported results should not be considered as an indication of future performance. Important risks and uncertainties that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: our ability to attract new members and enter new markets, including the need for certain governmental approvals; our ability to maintain a high rating for our health plans on the Five Star Quality Rating System; our ability to develop and maintain satisfactory relationships with care providers that service our members; risks associated with being a government contractor; changes in laws and regulations applicable to our business model; risks related to our indebtedness; changes in market or industry conditions and receptivity to our technology and services; results of litigation or a security incident; and the impact of shortages of qualified personnel and related increases in our labor costs. There can be no assurance that Alignment Healthcare will be able to complete the offering on the anticipated terms, or at all. For a detailed discussion of the risk factors that could affect our actual results, please refer to the risk factors identified in our Annual Report on Form 10-K for the year ended December 31, 2025, and the other periodic reports we file with the SEC. All information provided in this release is as of the date hereof, and we undertake no duty to update or revise this information unless required by law.

Investor Contact Harrison Zhuo hzhuo@ahcusa.com

Media Contact
Priya Shah
mPR, Inc. for Alignment Healthcare alignment@mpublicrelations.com

FAQ

What did Alignment Healthcare (ALHC) announce on March 2, 2026 about a stock offering?

Alignment Healthcare announced an underwritten public offering of 13,167,733 shares by a General Atlantic affiliate. According to the company, J.P. Morgan is the underwriter and the offering is made under an effective Form S-3 shelf registration.

Will Alignment Healthcare (ALHC) receive proceeds from the March 2, 2026 offering?

No, Alignment Healthcare will not receive any proceeds from the offering of the shares. According to the company, the shares are being sold by a selling stockholder, so all sale proceeds will go to that affiliate.

Who is selling the 13,167,733 shares in the Alignment Healthcare (ALHC) offering?

An affiliate of General Atlantic, L.P. is selling the 13,167,733 shares in the transaction. According to the company, the offering is a sale by that selling stockholder, not a company primary issuance.

Which firm is underwriting the Alignment Healthcare (ALHC) secondary offering?

J.P. Morgan is acting as the underwriter for the proposed offering. According to the company, prospectus supplements and the accompanying prospectus will describe offering terms and distribution details.

Under what registration is the Alignment Healthcare (ALHC) offering being made?

The offering is being made pursuant to a Form S-3 shelf registration that became effective March 2, 2026. According to the company, the offering will be made only by a prospectus supplement and accompanying prospectus.